Dr Reddy's Board to meet Oct 23 to consider Q2 FY27 results

Dr. Reddy's Laboratories Ltd. announced that its Board of Directors will convene on October 23, 2026. The primary agenda for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended September 30, 2026. Additionally, the company informed about the closure of the trading window for its securities. The trading window will remain closed from September 24, 2026, until October 25, 2026, inclusive, in compliance with SEBI insider trading regulations.